Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat
暂无分享,去创建一个
J. Taylor | K. Khalili | J. Rappaport | C. Chang | M. Chowdhury | J. Taylor | J. Taylor | Mohammed S. Chowdhury | C. Chang
[1] H. Mayan,et al. [AIDS dementia]. , 2020, Harefuah.
[2] R. Gaynor,et al. tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. , 1991, Genes & development.
[3] B Tidor,et al. Arginine-mediated RNA recognition: the arginine fork , 1991, Science.
[4] D. Hudson,et al. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. , 1991, Genes & development.
[5] J. Taylor,et al. Regulation of the human neurotropic virus promoter by JCV-T antigen and HIV-1 tat protein. , 1990, Oncogene.
[6] T. Okamoto,et al. Transcriptional activation from the long-terminal repeat of human immunodeficiency virus in vitro. , 1990, Virology.
[7] D. Gabuzda. Neurologic disorders associated with HIV infections. , 1990, Journal of the American Academy of Dermatology.
[8] S. Salahuddin,et al. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients , 1990, Nature.
[9] K. Khalili,et al. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[10] N. Sonenberg,et al. Structural requirements for trans activation of human immunodeficiency virus type 1 long terminal repeat-directed gene expression by tat: importance of base pairing, loop sequence, and bulges in the tat-responsive sequence , 1990, Journal of virology.
[11] K. Khalili,et al. The acidic amino-terminal region of the HIV-1 Tat protein constitutes an essential activating domain. , 1989, The New biologist.
[12] B. Cullen,et al. Regulatory pathways governing HIV-1 replication , 1989, Cell.
[13] R. Gaynor,et al. Specific binding of a HeLa cell nuclear protein to RNA sequences in the human immunodeficiency virus transactivating region. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[14] L. Frumkin. AIDS in the Nervous System , 1989 .
[15] K. Khalili,et al. Cell type-specific expression of JC virus early promoter is determined by positive and negative regulation , 1989, Journal of virology.
[16] Carl O. Pabo,et al. Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.
[17] M. Ptashne. How eukaryotic transcriptional activators work , 1988, Nature.
[18] R. Gaynor,et al. Functional domains required for tat‐induced transcriptional activation of the HIV‐1 long terminal repeat. , 1988, The EMBO journal.
[19] Eric C. Holland,et al. HIV-1 tat trans-activation requires the loop sequence within tar , 1988, Nature.
[20] M. Post,et al. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. , 1987, Annals of internal medicine.
[21] J. Brady,et al. Spacing between simian virus 40 early transcriptional control sequences is important for regulation of early RNA synthesis and gene expression , 1986, Journal of virology.
[22] B. Navia,et al. The AIDS dementia complex: II. Neuropathology , 1986, Annals of neurology.
[23] S. Kenney,et al. Mapping 5' termini of JC virus late RNA , 1986, Journal of virology.
[24] G. Khoury,et al. JC virus enhancer-promoter active in human brain cells. , 1984, Science.
[25] P Gruss,et al. Characterization of enhancer elements in the long terminal repeat of Moloney murine sarcoma virus , 1984, Journal of virology.
[26] B. Howard,et al. Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells , 1982, Molecular and cellular biology.
[27] B. Padgett,et al. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. , 1973, The Journal of infectious diseases.
[28] A. van der Eb,et al. A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.
[29] J. Lisziewicz,et al. Tat-regulated production of multimerized TAR RNA inhibits HIV-1 gene expression. , 1991, The New biologist.
[30] N. Sonenberg,et al. A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. , 1990, Genes & development.
[31] M. Smith,et al. Oligonucleotide-directed mutagenesis of DNA fragments cloned into M13 vectors. , 1983, Methods in enzymology.